Platelet-targeted pharmacologic treatments as anti-cancer therapy.

about

Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy.Prognostic and clinicopathological significance of platelet to lymphocyte ratio in esophageal cancer: a meta-analysis.

P2860

Q50002204-39A646E2-7521-4DE2-A53F-6386B9CA8D24 Q54939284-D02125A2-299A-48A4-A03D-62483A56C20D

P2860

Platelet-targeted pharmacologic treatments as anti-cancer therapy.

Item

http://www.wikidata.org/entity/Q38657846

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Platelet-targeted pharmacologic treatments as anti-cancer therapy.

@en

type

Item

label

Platelet-targeted pharmacologic treatments as anti-cancer therapy.

@en

prefLabel

Platelet-targeted pharmacologic treatments as anti-cancer therapy.

@en

P1476

Platelet-targeted pharmacologic treatments as anti-cancer therapy.

@en

P2093

M Malvestiti

http://www.w3.org/2001/XMLSchema#string

M Sebastiano

http://www.w3.org/2001/XMLSchema#string

P Gresele

http://www.w3.org/2001/XMLSchema#string

S Momi

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the platelet ADP receptor targeted by antithrombotic drugs

Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain

Thrombin receptor overexpression in malignant and physiological invasion processes

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Central role of the P2Y12 receptor in platelet activation

A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

Particle margination and its implications on intravenous anticancer drug delivery

P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells

PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis

P2888

s10555-017-9679-8

P31

scholarly article

P356

10.1007/S10555-017-9679-8

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090666662

http://www.w3.org/2001/XMLSchema#string

P698

28707198

http://www.w3.org/2001/XMLSchema#string

Platelet-targeted pharmacologic treatments as anti-cancer therapy.

about

P2860

P2860

Platelet-targeted pharmacologic treatments as anti-cancer therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698